Abbott Laboratories talks three-part notes offer for Thursday pricing

By Aleesia Forni

Virginia Beach, March 5 – Abbott Laboratories set price talk for a planned three-part offering of senior notes (A2/A+/) on Thursday, according to an informed source and a 424B3 filed with the Securities and Exchange Commission.

A tranche of notes due 2020 is talked in the 60 basis points area over Treasuries while a tranche due 2022 is talked in the 80 bps area over Treasuries.

Talk for a tranche of notes due 2025 is set in the area of Treasuries plus 100 bps.

The bookrunners are Barclays, BofA Merrill Lynch, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC.

BNP Paribas Securities Corp. is an additional bookrunner for the 2020 notes, Deutsche Bank Securities Inc. is an additional bookrunner for the 2025 notes and Societe Generale is an additional bookrunner for the notes due 2022.

The pharmaceutical health care products company is based in Abbott Park, Ill.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.